harmonet coat. tabl.
pfizer sa-nv - ethinylestradiol 0,02 mg; gestodene 0,075 mg - coated tablet - ethinylestradiol 20 µg; gestodene 75 µg - gestodene and ethinylestradiol
lindynette 20 0.02 mg - 0.075 mg coat. tabl.
gedeon richter plc - ethinylestradiol 0,02 mg; gestodene 0,075 mg - coated tablet - 0,020 mg - 0,075 mg - ethinylestradiol 20 µg; gestodene 75 µg - gestodene and ethinylestradiol
lindynette 30 75 µg - 30 µg coat. tabl.
gedeon richter plc - ethinylestradiol 0,03 mg; gestodene 0,075 mg - coated tablet - 75 µg - 30 µg - ethinylestradiol 30 µg; gestodene 75 µg - gestodene and ethinylestradiol
liosanne 30 0,075 mg - 0,030 mg coat. tabl.
sandoz sa-nv - gestodene 75 µg; ethinylestradiol 30 µg - coated tablet - 0,075 mg - 0,030 mg - ethinylestradiol 30 µg; gestodene 75 µg - gestodene and ethinylestradiol
meliane 0.075 mg - 0.02 mg coat. tabl.
bayer sa-nv - ethinylestradiol 0,02 mg; gestodene 0,075 mg - coated tablet - 0,075 mg - 0,02 mg - ethinylestradiol 20 µg; gestodene 75 µg - gestodene and ethinylestradiol
minulet 0.075 mg - 0.03 mg coat. tabl.
pfizer sa-nv - ethinylestradiol 0,03 mg; gestodene 0,075 mg - coated tablet - 0,075 mg - 0,030 mg - ethinylestradiol 0.03 mg; gestodene 0.07 mg - gestodene and ethinylestradiol
mirelle 60 µg - 15 µg film-coat. tabl.
bayer sa-nv - gestodene 60 µg (light yellow tablet); ethinylestradiol 15 µg (light yellow tablet); placebo (white tablet) - film-coated tablet - 60 µg - 15 µg - ethinylestradiol 15 µg; gestodene 60 µg; placebo - gestodene and ethinylestradiol
yana drospirenone 3 mg and ethinylestradiol 20 microgram film coated tablet blister pack
arrotex pharmaceuticals pty ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; povidone; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - this medicine is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception. ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg /ethinylestradiol 20 ?g for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg /ethinylestradiol 20 ?g has not been evaluated for treatment of pms (premenstrual syndrome), see section 5.1 pharmacodynamic properties - clinical trials.
harmonet 75/20 microgram coated tablets
pfizer healthcare ireland - gestodene ethinylestradiol - coated tablets - 75/20 microgram
ethinylestradiol / drospirenone leon farma 0.03mg/3 mg film-coated tablets
laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.03 / 3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol